ODISHA
Covid-19 drugs Remdesivir, FabiFlu to be available in Odisha
Remdesivir is an injective vial, manufactured by Hyderabad-based pharma company Hetero, and is recommended for critical patients. Hetero supplied its first batch of the vials to states such as Maharashtra, Delhi, Gujarat, Tamil Nadu and Telengana. In the second phase, the company would send the vials to Bhubaneswar, besides Kolkata, Indore, Bhopal, Lucknow, Patna, Ranchi, Vijayawada, Kochi, Thiruvananthapuram and Goa. The company has announced to price Covifor at Rs 5,400 per vial.
Covifor is the first generic brand of remdesivir originally manufactured by US-based Gilead Sciences. It would be available in both government and private hospitals. Some other pharmaceutical companies are also in the process of rolling out remdesivir, originally developed to treat hepatitis C and was tested against Ebola.
INTERNATIONAL
IMF says Indian economy will contract by 4.5% in 2020-’21
The International Monetary Fund announced that India’s Gross Domestic Product will contract by 4.5% in the 2020-’21 financial year.
This is much lower than the 1.9% positive growth the IMF had forecast in its World Economic Outlook for April.
India had imposed a nationwide lockdown on March 25. The lockdown was slowly eased, and by June 1, most non-essential services had been allowed to operate in non-containment zones in the country, subject to policies made by states.
The report said that the Indian economy will bounce back in 2021-’22 with a growth rate of around 6%.
The IMF also said that the world economy will experience an even deeper recession in 2020-’21. It will contract by 4.9% in 2020-’21.
The United States economy will contract by a whopping 8%, the IMF said.
NATIONAL
Government approves 2% interest subsidy to ‘Shishu’ borrowers under Mudra Yojna
The government announced a 2% interest subvention to borrowers under the ‘Shishu’ category of the flagship Pradhan Mantri MUDRA Yojana (PMMY).
Under the Shishu category, collateral free loans of up to 50,000 will be given to beneficiaries.
Launched in 2015, the Pradhan Mantri MUDRA Yojana provides loans up to 10 lakh to non-corporate, non-farm small/micro enterprises.
These loans are classified as MUDRA loans under PMMY.
Commercial banks, RRBs, small finance banks, MFIs and NBFCs provide MUDRA loans.
NITI Aayog launched Behaviour Change Campaign Navigating the New Normal and Website
NITI Aayog, in partnership with Bill and Melinda Gates Foundation (BMGF), Centre for Social and Behavioural Change (CSBC), Ashoka University, and the Ministries of Health and Ministry of Women and Child Development launched a behaviour change campaign called ‘Navigating the New Normal’, and its website on 25 June. Around 92,000 Non-Governmental Organisation (NGOs) and civil society organizations (CSOs) working with NITI Aayog participated in the virtual launch via a webcast.
The campaign focuses on COVID-19-safe behaviours, especially wearing masks, during the ‘Unlock’ phase of the ongoing pandemic.
The campaign & website was developed under the guidance of Empowered Group 6, constituted by the Government of India and chaired by CEO, NITI Aayog.
Dr. Harsh Vardhan launched eBloodServices Mobile App
Union Minister of Health & Family Welfare Dr. Harsh Vardhan launched the ‘eBloodServices’ mobile App on 25 June 2020 through video conferencing. The app was developed by the Indian Red Cross Society (ICRS). The Union Health Minister is the Chairman of the Indian Red Cross Society.
eBloodServices Mobile App is developed by the E-Raktkosh team of Centre for Development of Advanced Computing (CDAC) under the Digital India scheme launched by Prime Minister Shri Narendra Modi in 2015.
This Blood Donation App is a prime example of how the Digital India Scheme is serving the need for accessing blood services.
Through this App, four units of blood can be requisitioned at a time and the blood bank will wait for as long as 12 hours for the person to collect it.
This app makes it easy for those in need to request for Blood units at IRCS NHQ.
Amid the COVID-19 pandemic, the Mobile App will provide succor to all those who direly require blood.
The NHQ Blood Bank conducted 55 blood donation camps collecting 2896 units of blood. A total of 5221 units were collected during the lockdown period.
Researchers finds new biomolecules to fight drug resistance in Kala-azar
Researchers at the Department of Biotechnology’s National Centre for Cell Science (DBT-NCCS) in Pune discovered new biomolecules to fight drug resistance in Kala-azar exploring ways to tackle miltefosine resistance.
The researchers worked with one of the species of Leishmania that causes infection, called Leishmania major. The researchers manipulated the transporter proteins in the species in a manner that would result in increased uptake of the drug and decrease in its being thrown out of the parasite’s body.
The researcher used a computational method to design small molecules, called peptides, that could very specifically interact with the transporter proteins of L. major alone, and not interfere with human proteins in any way.
Specific types of protein molecules called transporter proteins to play a major role in carrying miltefosine into and out of the parasite’s body, which comprises a single cell.
OPSC Notes brings Prelims and Mains programs for OPSC Prelims and OPSC Mains Exam preparation. Various Programs initiated by OPSC Notes are as follows:-- OPSC Mains Tests and Notes Program
- OPSC Prelims Exam 2020- Test Series and Notes Program
- OPSC Prelims and Mains Tests Series and Notes Program
- OPSC Detailed Complete Prelims Notes